MétaCan
Menu
Back to cohort
Record W4385463418 · doi:10.1093/jacamr/dlad091

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

2023· article· en· W4385463418 on OpenAlexfundno aff
Ioannis Baltas, Mark Gilchrist, Eirini Koutoumanou, Malick M. Gibani, James Meiring, Akaninyene Otu, David Hettle, Ameeka Thompson, James Price, Anna Crepet, Abolaji Atomode, Timothy Crocker-Buque, Dimitrios Spinos, Hudson Guyver, Matija Tausan, Donald Somasunderam, Maxwell Thoburn, Cathleen Chan, Helen Umpleby, Bethany Sharp, Callum Chivers, Devan Vaghela, Ronak J Shah, Jonathan D. Foster, Amy Hume, Christopher Smith, Ammara Asif, Dimitrios Mermerelis, Mohammad Abbas Reza, Dominic A. Haigh, Thomas Lamb, Loucia Karatzia, Alexandra Bramley, Nikhil Kadam, Konstantinos Kavallieros, Veronica Garcia-Arias, Jane Democratis, Claire S. Waddington, Luke Moore, Alexander M. Aiken

Bibliographic record

VenueJAC-Antimicrobial Resistance · 2023
Typearticle
Languageen
FieldImmunology and Microbiology
TopicAntibiotic Use and Resistance
Canadian institutionsnot available
FundersLondon School of Hygiene and Tropical MedicineShionogiMcGill University
KeywordsAntimicrobial stewardshipCeftazidime/avibactamAntimicrobialStenotrophomonas maltophiliaMedicineCarbapenemInfection controlMeropenemIntensive care medicinePsychological interventionCeftazidimeAntibiotic resistanceAntibioticsPseudomonas aeruginosaMicrobiologyBiologyNursing

Abstract

fetched live from OpenAlex

Abstract Objectives A novel ‘subscription-type’ funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked antimicrobial funding model. Methods An online survey was sent to all infection consultants in NHS acute hospitals in England. Results The response rate was 31.2% (235/753). Most consultants agreed the model is a welcome development (69.8%, 164/235), will improve treatment of drug-resistant infections (68.5%, 161/235) and will stimulate research and development of new antimicrobials (57.9%, 136/235). Consultants disagreed that the model would lead to reduced carbapenem use and reported increased use of cefiderocol post-implementation. The presence of an antimicrobial pharmacy team, requirement for preauthorization by infection specialists, antimicrobial stewardship ward rounds and education of infection specialists were considered the most effective antimicrobial stewardship interventions. Under the new model, 42.1% (99/235) of consultants would use these antimicrobials empirically, if risk factors for antimicrobial resistance were present (previous infection, colonization, treatment failure with carbapenems, ward outbreak, recent admission to a high-prevalence setting). Significantly higher insurance and diversity values were given to model antimicrobials compared with established treatments for carbapenem-resistant infections, while meropenem recorded the highest enablement value. Use of both ‘subscription-type’ model drugs for a wide range of infection sites was reported. Respondents prioritized ceftazidime/avibactam for infections by bacteria producing OXA-48 and KPC and cefiderocol for those producing MBLs and infections with Stenotrophomonas maltophilia, Acinetobacter spp. and Burkholderia cepacia. Conclusions The ‘subscription-type’ model was viewed favourably by infection consultants in England.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.044
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.058
Threshold uncertainty score0.115

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.044
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0020.003
Scholarly communication0.0050.004
Open science0.0010.005
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.198
GPT teacher head0.322
Teacher spread0.125 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designQualitative
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJAC-Antimicrobial ResistanceSame topicAntibiotic Use and ResistanceFrench-language works237,207